Literature DB >> 10464164

Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response.

L Harling-McNabb1, G Deliyannis, D C Jackson, S Gerondakis, G Grigoriadis, L E Brown.   

Abstract

Rel, a haemopoietic cell-restricted member of the NF-kappaB/Rel family of transcription factors, has recently been shown to be important in the function of B and T lymphocytes. In an attempt to understand the role of this protein in the immune response, we examined the ability of Rel(-/-) mice to counter an influenza virus infection. Normal levels of virus-specific cytotoxic T cells induced in Rel(-/-) mice were able to clear virus from the lungs, albeit with somewhat delayed kinetics compared to normal mice. Rel(-/-) mice did, however, display a markedly reduced T cell proliferative response to the virus, and exhibited impaired local and systemic influenza virus-specific antibody responses. This defect was sufficient to result in an inability of vaccinated mice, but not of previously infected mice, to acquire antibody-dependent protective immunity to reinfection with the same virus. These findings establish that during the response to influenza virus, Rel function allows optimal development of humoral immunity, a role that apparently cannot be fulfilled by other NF-kappaB/Rel proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464164     DOI: 10.1093/intimm/11.9.1431

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  25 in total

1.  A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.

Authors:  G Deliyannis; J S Boyle; J L Brady; L E Brown; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 3.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 4.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

5.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

6.  Critical role of cRel subunit of NF-κB in sepsis survival.

Authors:  Emilie Courtine; Frédéric Pène; Nicolas Cagnard; Julie Toubiana; Catherine Fitting; Jessy Brocheton; Christophe Rousseau; Steve Gerondakis; Jean-Daniel Chiche; Fatah Ouaaz; Jean-Paul Mira
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

7.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

8.  c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells.

Authors:  Iwao Isomura; Stephanie Palmer; Raelene J Grumont; Karen Bunting; Gerard Hoyne; Nancy Wilkinson; Ashish Banerjee; Anna Proietto; Raffi Gugasyan; Li Wu; Wu Li; Alice McNally; Raymond J Steptoe; Ranjeny Thomas; M Frances Shannon; Steve Gerondakis
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

Review 9.  NF-kappaB and virus infection: who controls whom.

Authors:  M Gabriella Santoro; Antonio Rossi; Carla Amici
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Enhanced survival of lung tissue-resident memory CD8⁺ T cells during infection with influenza virus due to selective expression of IFITM3.

Authors:  Linda M Wakim; Nishma Gupta; Justine D Mintern; Jose A Villadangos
Journal:  Nat Immunol       Date:  2013-01-27       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.